Drugs@FDA document

SEVELAMER CARBONATE Letter · ANDA 207179 ORIG-1

Drugs@FDA document · AUROBINDO PHARMA · Aug 7, 2017

Key facts

Drug name SEVELAMER CARBONATE
Document type Letter
Application ANDA207179
Submission ORIG-1
Company AUROBINDO PHARMA
Document date Aug 7, 2017
FDA document accessdata.fda.gov

At a glance

  • 1–9 Documents for this application

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents